What to Look for in FedEx Earnings
FedEx is scheduled to report its fiscal third-quarter financial results Wednesday after the markets close.
All Work
Chris Lange
SEC Charges Microcap With Misleading Investors
The SEC has charged a microcap company's CEO for falsely claiming to have a lucrative relationship with the United Nations and billions of dollars in clean energy contracts with foreign governments.
SEC Settles With AIG Affiliates
The SEC has announced charges against three AIG affiliates for steering mutual fund clients toward more expensive share classes so the firms could collect more fees.
Aeglea BioTherapeutics Prepares for IPO
Aeglea BioTherapeutics has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids
One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be removed from the market, creating a huge risk and opportunity in the space.
Valeant Pharma Trips Over Preliminary Earnings and Guidance
Valeant Pharmaceuticals International reported mixed preliminary fourth-quarter financial results before the markets opened on Tuesday.
Jefferies Top Drug Stocks for the Rest of 2016
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Solazyme Stuns Investors With Bottom Line Beat
Solazyme reported mixed fourth-quarter financial results and a deal with Unilever after the markets closed on Monday.
What to Look for in Oracle Earnings
Oracle is scheduled to report its fiscal third-quarter financial results after the markets close on Tuesday.
SEC Settles Charges With Texas Company for Faulty Evaluations of Internal Controls
The SEC has settled charges against Texas-based oil company Magnum Hunter Resources and several individuals for deficient evaluation of the company’s internal controls over financial reporting.
Vericel Trips Over Earnings
Vericel Corp. (NASDAQ: VCEL) reported its fourth-quarter financial results before the markets opened on Monday. The company said it had a net loss of $0.28 per share on $15.4 million in revenue, which compares…
How AMD Is Taking Over Virtual Reality
AMD made waves in the market Monday morning following its presentation at the 2016 Game Developer Conference.
SEC Announces Fraud Charges on California Man
The SEC has announced fraud charges against a California businessman accused of stealing investor assets and then trying to cover it up once the SEC caught onto his scheme.
Senseonics Gears Up for IPO
Senseonics Holdings has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing for the 18.2 million shares with…
SEC Charges Oregon Firm With Defrauding Investors
The SEC has charged an Oregon-based investment group and three top executives with hiding the rapidly deteriorating financial condition of its enterprise while raising millions from investors.
What to Expect From Valeant Pharma Q4 Earnings
Valeant Pharmaceuticals is scheduled to report its fourth-quarter preliminary results and update its 2016 financial guidance in a conference call Tuesday morning.
GW Pharma Explodes on Positive Late-Stage Results
GW Pharmaceuticals has announced the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex for the treatment of Dravet syndrome.
5 Key Earnings for the Week Ahead
24/7 Wall St. has put together a preview of FedEx, Oracle and some of the other major companies reporting their quarterly results this coming week.
5 Key FDA Decisions Expected in March
24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the trading range and price target.
Analysts Make Big Changes on Cybersecurity Stock Ratings
Recent analyst calls on some major companies in the cybersecurity field offer a picture of what analysts see in the industry and where it could stand to go in the coming months.